EPIQ Capital Group

AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies.

Zephyr AI is a healthcare technology company focused on transforming drug discovery and precision medicine. By leveraging large, complex datasets and proprietary algorithms, Zephyr AI aims to redefine drug development and streamline clinical trials. The company collaborates with leading health systems, health insurance plans, and biotechnology innovators to enhance the quality of care, improve patient outcomes, and reduce costs. Zephyr AI's innovative approach addresses challenges in clinical decision support and aims to combat various diseases, marking a significant shift in the traditional methods of healthcare delivery.

Tenstorrent Inc. is a Canadian company that develops and manufactures application-specific integrated circuits (ASIC) focused on artificial intelligence and machine learning. Founded in 2016 and headquartered in Toronto, with an additional office in Austin, Texas, Tenstorrent specializes in providing scalable and efficient hardware solutions for various applications, ranging from battery-powered Internet of Things (IoT) devices to large cloud servers. The company’s architecture supports deep learning and enables adaptability in algorithms, catering to developers and researchers in the technology sector. By offering advanced AI hardware and software, Tenstorrent aims to enhance computational performance and facilitate the growth of machine learning technologies.

Swift Navigation, Inc. is a technology company specializing in precise global positioning system (GPS) solutions, founded in 2012 and based in San Francisco, California, with an additional location in Melbourne, Australia. The company develops hardware and software that provide centimeter-level accuracy through real-time kinematics (RTK) technology. Its product lineup includes the Piksi Multi GNSS Module, a versatile RTK receiver, and the Duro Ruggedized Receiver, designed for various industrial applications such as agriculture and robotics. Additionally, Swift Navigation offers the Skylark cloud corrections service and the Starling GNSS positioning engine, which caters to automotive and autonomous vehicle needs. The company's innovative solutions, characterized by their affordability and high accuracy—100 times better than standard GPS—serve multiple industries, including unmanned aerial vehicles, surveying, and space applications. Swift Navigation's commitment to making advanced positioning technology accessible is recognized by notable accolades, including mentions in Inc. and Forbes 30 Under 30 lists.

Spotlight Therapeutics, Inc. specializes in the development of gene editing therapeutics designed to target specific cell populations directly within the body. Established in 2017 and based in Hayward, California, the company leverages a biotechnology platform that utilizes CRISPR nuclease effectors for in vivo gene editing. Its innovative approach aims to create next-generation programmable nucleases that enhance treatment options for a variety of conditions. Spotlight Therapeutics is focused on multiple therapeutic areas, including immuno-oncology, ophthalmology, and hematology, and is developing programs to address previously undruggable intracellular gene targets as well as specific monogenic disease targets related to the eye. This targeted gene editing strategy seeks to overcome the challenges associated with traditional delivery methods, thereby providing healthcare providers with improved tools for patient treatment.

Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

SalioGen Therapeutics is a biotechnology company focused on developing gene therapies for inherited disorders. Utilizing its proprietary Exact DNA Integration Technology (EDIT), the company employs mammal-derived enzymes, known as Saliogase, to facilitate genome engineering. This innovative approach enables the delivery of any size gene through non-viral methods, offering significant advantages in manufacturing and application. SalioGen's technology aims to provide durable, safe, and affordable treatments, potentially transforming the landscape of care for patients with genetic conditions and enhancing the efficiency of cell therapy and biologics manufacturing in the healthcare sector.

VideoAmp is a software and data company that develops an integrated platform aimed at transforming the advertising landscape by unifying traditional TV, streaming video, and digital media. Its innovative platform provides measurement and optimization tools that connect media exposures directly to an advertiser's sales, allowing for a more cohesive understanding of audience engagement. By facilitating transactions based on independent measurement as a multi-platform media currency, VideoAmp enables advertisers, agencies, and media sellers to align their strategies effectively. This approach not only optimizes brand marketing investments but also drives real business outcomes, creating efficiencies across various advertising channels.

Windfall Data, founded in 2016 and based in San Francisco, specializes in determining the net worth of households globally. The company offers an enterprise platform that utilizes proprietary algorithms and extensive data sets to deliver actionable consumer financial insights, which are updated weekly. This service is designed for both nonprofit and for-profit organizations, helping them identify and engage with their most promising constituents. Windfall Data's platform empowers its clients with data-driven insights that enhance marketing, sales, and analytics efforts, enabling businesses to prioritize affluent consumers effectively. Over 400 organizations currently leverage Windfall Data's services, supported by notable investors including Bullpen Capital and Industry Ventures.

Swift Navigation, Inc. is a technology company specializing in precise global positioning system (GPS) solutions, founded in 2012 and based in San Francisco, California, with an additional location in Melbourne, Australia. The company develops hardware and software that provide centimeter-level accuracy through real-time kinematics (RTK) technology. Its product lineup includes the Piksi Multi GNSS Module, a versatile RTK receiver, and the Duro Ruggedized Receiver, designed for various industrial applications such as agriculture and robotics. Additionally, Swift Navigation offers the Skylark cloud corrections service and the Starling GNSS positioning engine, which caters to automotive and autonomous vehicle needs. The company's innovative solutions, characterized by their affordability and high accuracy—100 times better than standard GPS—serve multiple industries, including unmanned aerial vehicles, surveying, and space applications. Swift Navigation's commitment to making advanced positioning technology accessible is recognized by notable accolades, including mentions in Inc. and Forbes 30 Under 30 lists.

Lineage Logistics is a leader in temperature-controlled supply chain and logistics, specializing in innovative, end-to-end solutions that enhance food safety and distribution efficiency. The company offers a wide range of services, including cold storage warehousing, automated warehousing, port-centric warehousing, sustainable warehousing, freight forwarding, drayage, and customs brokerage. By leveraging advanced technology and a comprehensive real estate network, Lineage aims to minimize supply chain waste and reduce environmental impact, thereby helping clients—from large corporations to smaller family-owned businesses—maintain the integrity of their temperature-sensitive products. Recognized for its innovative approach, Lineage has been acknowledged as a top data science company and has received accolades for its contributions to the logistics industry.

Lucira Health, Inc. is a medical technology company based in Emeryville, California, that specializes in the development and commercialization of innovative infectious disease test kits. Founded in 2013, the company focuses on creating accessible and user-friendly testing solutions, including a disposable COVID-19 test kit designed for home use. This kit provides centralized-laboratory-accurate molecular testing in a compact format that operates on two AA batteries. It connects consumers to treatment options through a mobile application and offers a dual testing capability to determine whether viral respiratory symptoms are caused by COVID-19 or influenza. Lucira Health aims to enhance the accessibility and efficiency of infectious disease diagnostics.

SpotOn is a technology company founded in 2017 by Doron Friedman, Matt Hyman, and Zach Hyman, headquartered in San Francisco, California. The company specializes in providing innovative software and payment solutions tailored for small and midsize businesses. SpotOn offers a comprehensive, cloud-based platform that includes tools for payments, point-of-sale systems, marketing, website development, online ordering, appointments, eCommerce, digital loyalty, and review management. By integrating these services, SpotOn aims to enhance operational efficiency and customer engagement for its clients. The company's mission is to empower businesses by delivering high-quality solutions at fair prices, supported by personalized local service.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company focused on developing oral biologic product candidates aimed at treating autoimmune, inflammatory, metabolic, and other diseases. The company utilizes a proprietary technology platform that enables the active transport of therapeutic agents across the intestinal epithelium, leveraging natural cellular trafficking pathways. Its lead candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis and is set to enter Phase 2 trials. Additionally, the company is advancing AMT-126, an oral fusion protein targeting intestinal epithelium barrier function defects. Applied Molecular Transport is dedicated to creating patient-friendly oral formulations, such as tablets and capsules, to enhance treatment accessibility and efficacy. Founded in 2010 and headquartered in South San Francisco, California, the company is building a diverse portfolio of therapeutic modalities, including peptides, proteins, antibodies, and RNA therapeutics.

Lucira Health, Inc. is a medical technology company based in Emeryville, California, that specializes in the development and commercialization of innovative infectious disease test kits. Founded in 2013, the company focuses on creating accessible and user-friendly testing solutions, including a disposable COVID-19 test kit designed for home use. This kit provides centralized-laboratory-accurate molecular testing in a compact format that operates on two AA batteries. It connects consumers to treatment options through a mobile application and offers a dual testing capability to determine whether viral respiratory symptoms are caused by COVID-19 or influenza. Lucira Health aims to enhance the accessibility and efficiency of infectious disease diagnostics.

Swift Navigation, Inc. is a technology company specializing in precise global positioning system (GPS) solutions, founded in 2012 and based in San Francisco, California, with an additional location in Melbourne, Australia. The company develops hardware and software that provide centimeter-level accuracy through real-time kinematics (RTK) technology. Its product lineup includes the Piksi Multi GNSS Module, a versatile RTK receiver, and the Duro Ruggedized Receiver, designed for various industrial applications such as agriculture and robotics. Additionally, Swift Navigation offers the Skylark cloud corrections service and the Starling GNSS positioning engine, which caters to automotive and autonomous vehicle needs. The company's innovative solutions, characterized by their affordability and high accuracy—100 times better than standard GPS—serve multiple industries, including unmanned aerial vehicles, surveying, and space applications. Swift Navigation's commitment to making advanced positioning technology accessible is recognized by notable accolades, including mentions in Inc. and Forbes 30 Under 30 lists.

Lucira Health, Inc. is a medical technology company based in Emeryville, California, that specializes in the development and commercialization of innovative infectious disease test kits. Founded in 2013, the company focuses on creating accessible and user-friendly testing solutions, including a disposable COVID-19 test kit designed for home use. This kit provides centralized-laboratory-accurate molecular testing in a compact format that operates on two AA batteries. It connects consumers to treatment options through a mobile application and offers a dual testing capability to determine whether viral respiratory symptoms are caused by COVID-19 or influenza. Lucira Health aims to enhance the accessibility and efficiency of infectious disease diagnostics.

Tenstorrent Inc. is a Canadian company that develops and manufactures application-specific integrated circuits (ASIC) focused on artificial intelligence and machine learning. Founded in 2016 and headquartered in Toronto, with an additional office in Austin, Texas, Tenstorrent specializes in providing scalable and efficient hardware solutions for various applications, ranging from battery-powered Internet of Things (IoT) devices to large cloud servers. The company’s architecture supports deep learning and enables adaptability in algorithms, catering to developers and researchers in the technology sector. By offering advanced AI hardware and software, Tenstorrent aims to enhance computational performance and facilitate the growth of machine learning technologies.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company focused on developing oral biologic product candidates aimed at treating autoimmune, inflammatory, metabolic, and other diseases. The company utilizes a proprietary technology platform that enables the active transport of therapeutic agents across the intestinal epithelium, leveraging natural cellular trafficking pathways. Its lead candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis and is set to enter Phase 2 trials. Additionally, the company is advancing AMT-126, an oral fusion protein targeting intestinal epithelium barrier function defects. Applied Molecular Transport is dedicated to creating patient-friendly oral formulations, such as tablets and capsules, to enhance treatment accessibility and efficacy. Founded in 2010 and headquartered in South San Francisco, California, the company is building a diverse portfolio of therapeutic modalities, including peptides, proteins, antibodies, and RNA therapeutics.

Quince Therapeutics is a preclinical stage biopharmaceutical company dedicated to developing innovative precision therapeutics for debilitating and rare diseases. The company has created a unique bone-targeting drug platform that enables the precise delivery of small molecules, peptides, or large molecules directly to the site of bone fractures and diseases. This targeted approach aims to enhance healing rates while minimizing off-target safety concerns often associated with non-targeted therapies. Quince Therapeutics focuses on addressing impairments related to strength, functionality, debilitating pain, and other serious health challenges.